SEQIRUS

SL STRATEGIES, LLC representing SEQIRUS · Q1 2026 · $45,000 · view on lda.senate.gov ↗

Issues lobbied

BUDBudget/Appropriations
Fiscal Year 2027 HHS Appropriations bills
HCRHealth Issues
Policies impacting seasonal and pandemic influenza response

Key facts

Filing UUID: a5bb142b-63e7-426c-8fbf-9427e135b8f7
Filing type: Q1
Filing period: first_quarter
Filing year: 2026
Posted: 2026-05-04T21:54:37-04:00
Registrant (lobbyist): SL STRATEGIES, LLC
Client: SEQIRUS
Client location: NJ / US
Client description: pharmaceutical company
Income reported: $45,000
Expenses reported: —